The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koenders, M. I.
Right arrow Articles by van den Berg, W. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koenders, M. I.
Right arrow Articles by van den Berg, W. B.
The Journal of Immunology, 2006, 176: 6262-6269.
Copyright © 2006 by The American Association of Immunologists

Interleukin-17 Acts Independently of TNF-{alpha} under Arthritic Conditions1

Marije I. Koenders2,*, Erik Lubberts3,*, Fons A. J. van de Loo*, Birgitte Oppers-Walgreen*, Liduine van den Bersselaar*, Monique M. Helsen*, Jay K. Kolls, Franco E. Di Padova{dagger}, Leo A. B. Joosten* and Wim B. van den Berg*

* Experimental Rheumatology and Advanced Therapeutics, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands; {dagger} Children’s Hospital of Pittsburgh, Department of Pediatric and Pulmonology, Pittsburgh, PA 15213; {ddagger} Novartis Institutes for Biomedical Research, Basel, Switzerland

The proinflammatory T cell cytokine IL-17 is a potent inducer of other cytokines such as IL-1 and TNF-{alpha}. The contribution of TNF in IL-17-induced joint inflammation is unclear. In this work we demonstrate using TNF-{alpha}-deficient mice that TNF-{alpha} is required in IL-17-induced joint pathology under naive conditions in vivo. However, overexpression of IL-17 aggravated K/BxN serum transfer arthritis to a similar degree in TNF-{alpha}-deficient mice and their wild-type counterparts, indicating that the TNF dependency of IL-17-induced pathology is lost under arthritic conditions. Also, during the course of the streptococcal cell wall-induced arthritis model, IL-17 was able to enhance inflammation and cartilage damage in the absence of TNF. Additional blocking of IL-1 during IL-17-enhanced streptococcal cell wall-induced arthritis did not reduce joint pathology in TNF-deficient mice, indicating that IL-1 is not responsible for this loss of TNF dependency. These data provide further understanding of the cytokine interplay during inflammation and demonstrate that, despite a strong TNF dependency under naive conditions, IL-17 acts independently of TNF under arthritic conditions.




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
D. Cihakova, J. G. Barin, M. Afanasyeva, M. Kimura, D. Fairweather, M. Berg, M. V. Talor, G. C. Baldeviano, S. Frisancho, K. Gabrielson, et al.
Interleukin-13 Protects Against Experimental Autoimmune Myocarditis by Regulating Macrophage Differentiation
Am. J. Pathol., May 1, 2008; 172(5): 1195 - 1208.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Yamaguchi, K. Fujio, H. Shoda, A. Okamoto, N. H. Tsuno, K. Takahashi, and K. Yamamoto
IL-17B and IL-17C Are Associated with TNF-{alpha} Production and Contribute to the Exacerbation of Inflammatory Arthritis
J. Immunol., November 15, 2007; 179(10): 7128 - 7136.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
W. B van den Berg, P. L van Lent, L. A B Joosten, S. Abdollahi-Roodsaz, and M. I Koenders
Amplifying elements of arthritis and joint destruction
Ann Rheum Dis, November 1, 2007; 66(suppl_3): iii45 - iii48.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. N. Patel, C. A. King, S. R. Bailey, J. W. Holt, K. Venkatachalam, A. Agrawal, A. J. Valente, and B. Chandrasekar
Interleukin-17 Stimulates C-reactive Protein Expression in Hepatocytes and Smooth Muscle Cells via p38 MAPK and ERK1/2-dependent NF-{kappa}B and C/EBPbeta Activation
J. Biol. Chem., September 14, 2007; 282(37): 27229 - 27238.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
M I Koenders, L A B Joosten, and W B van den Berg
Potential new targets in arthritis therapy: interleukin (IL)-17 and its relation to tumour necrosis factor and IL-1 in experimental arthritis
Ann Rheum Dis, November 1, 2006; 65(suppl_3): iii29 - iii33.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.